NCT01616121|CompletedPhase 3DMC
Loading search results
Sponsor study identifier
interventional
654
1 country
1
Study Start
June 1, 2002
Actual (reported)Primary Completion
July 1, 2014
Actual (reported)Study Completion
July 1, 2014
Actual (reported)It is well-known that 20-25% of patients hospitalized for acute myocardial infarction will develop acute heart failure during their hospitalization. Currently, the investigators have no reliable parameter for prediction of evolving acute heart failure in such a group of patients. As a result, the investigators have no way of preventing acute heart failure. Treatment of these patients only begins after appearance of clinical signs of acute heart failure. Lung impedance monitoring may be a good non-invasive parameter for prediction of evolving acute heart failure. This study will attempt to address whether preemptive lung impedance-guided therapy may prevent the development of overt acute heart failure and improve their clinical outcome.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 1, 2014
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 1, 2002
Actual (reported)May 31, 2012
Actual (reported)June 11, 2012
Actual (reported)July 1, 2014
Actual (reported)July 1, 2014
Actual (reported)Prevention of acute heart failure development in acute MI patients
Three years
Improvement of clinical outcome in patients with lung impedance-guided treatments
Three years
Conventional Treatment
Lung Impedance-Guided Therapy
Non-invasive lung impedance monitor (RSMM Company, Tel Aviv, Israel)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Hillel Yaffe Medical Center
Hadera, 38100, Israel
654 participants (actual enrollment reported by the registry).
First Submitted
May 31, 2012
First Posted
June 11, 2012
Study Start
June 1, 2002
Contact the study team to confirm eligibility.
Primary Completion
July 1, 2014
Actual (reported)Study Completion
July 1, 2014
Actual (reported)Last Updated
June 19, 2020
Record last verified: 2020-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: